Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Intracerebral administration of heat-inactivated Staphylococcus epidermidis enhances oncolysis and prolongs survival in a 9L orthotopic gliosarcoma model.

Löhr M, Molcanyi M, Poggenborg J, Spuentrup E, Runge M, Röhn G, Härtig W, Hescheler J, Hampl JA.

Cell Physiol Biochem. 2013;31(4-5):614-24. doi: 10.1159/000350081. Epub 2013 May 6.

2.
3.

Increase in tumor size following intratumoral injection of immunostimulatory CpG-containing oligonucleotides in a rat glioma model.

Ginzkey C, Eicker SO, Marget M, Krause J, Brecht S, Westphal M, Hugo HH, Mehdorn HM, Steinmann J, Hamel W.

Cancer Immunol Immunother. 2010 Apr;59(4):541-51. doi: 10.1007/s00262-009-0771-y. Epub 2009 Oct 2.

PMID:
19798500
4.

Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.

Giezeman-Smits KM, Okada H, Brissette-Storkus CS, Villa LA, Attanucci J, Lotze MT, Pollack IF, Bozik ME, Chambers WH.

Cancer Res. 2000 May 1;60(9):2449-57.

5.

A novel experimental in vivo model of cerebral immunomodulation induced by inactivated Staphylococcus epidermidis.

Löhr M, Molcanyi M, Stenzel W, Seifert H, Tzouras G, Röhn G, Mohseni D, Hampl JA.

J Neurosci Methods. 2012 Jan 15;203(1):89-95. doi: 10.1016/j.jneumeth.2011.09.016. Epub 2011 Sep 22.

PMID:
21963575
6.

Microglia phagocytose alloreactive CTL-damaged 9L gliosarcoma cells.

Kulprathipanja NV, Kruse CA.

J Neuroimmunol. 2004 Aug;153(1-2):76-82.

PMID:
15265665
7.

Tumor immunity within the central nervous system stimulated by recombinant Listeria monocytogenes vaccination.

Liau LM, Jensen ER, Kremen TJ, Odesa SK, Sykes SN, Soung MC, Miller JF, Bronstein JM.

Cancer Res. 2002 Apr 15;62(8):2287-93.

8.

Characterization of the 9L gliosarcoma implanted in the Fischer rat: an orthotopic model for a grade IV brain tumor.

Bouchet A, Bidart M, Miladi I, Le Clec'h C, Serduc R, Coutton C, Regnard P, Khalil E, Dufort S, Lemasson B, Laissue J, Pelletier L, Le Duc G.

Tumour Biol. 2014 Jul;35(7):6221-33. doi: 10.1007/s13277-014-1783-6. Epub 2014 Mar 16.

PMID:
24633919
9.

[Experimental study of dendritic cells transfected with cancer stem like cells RNA against 9L brain tumors].

Xiao ZY, Chen XJ, Yang Y, Xu RX.

Beijing Da Xue Xue Bao. 2015 Aug 18;47(4):661-6. Chinese.

10.

Paracrine delivery of IL-12 against intracranial 9L gliosarcoma in rats.

DiMeco F, Rhines LD, Hanes J, Tyler BM, Brat D, Torchiana E, Guarnieri M, Colombo MP, Pardoll DM, Finocchiaro G, Brem H, Olivi A.

J Neurosurg. 2000 Mar;92(3):419-27.

PMID:
10701528
11.

Effects of combined granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2, and interleukin-12 based immunotherapy against intracranial glioma in the rat.

Jean WC, Spellman SR, Wallenfriedman MA, Flores CT, Kurtz BP, Hall WA, Low WC.

J Neurooncol. 2004 Jan;66(1-2):39-49.

PMID:
15015768
12.

Immunological responsiveness to interleukin-2-producing brain tumors can be restored by concurrent subcutaneous transplantation of the same tumors.

Iwadate Y, Tagawa M, Namba H, Oga M, Kawamura K, Tasaki K, Sakiyama S, Yamaura A.

Cancer Gene Ther. 2000 Sep;7(9):1263-9.

13.

TGF-beta2 inhibition augments the effect of tumor vaccine and improves the survival of animals with pre-established brain tumors.

Liu Y, Wang Q, Kleinschmidt-DeMasters BK, Franzusoff A, Ng KY, Lillehei KO.

J Neurooncol. 2007 Jan;81(2):149-62. Epub 2006 Aug 29.

PMID:
16941073
14.
15.

A 9L gliosarcoma transplantation model for studying adoptive immunotherapy into the brains of conscious rats.

Fleshner M, Watkins LR, Redd JM, Kruse CA, Bellgrau D.

Cell Transplant. 1992;1(4):307-12.

PMID:
1344303
16.

Analysis of interleukin 2 and various effector cell populations in adoptive immunotherapy of 9L rat gliosarcoma: allogeneic cytotoxic T lymphocytes prevent tumor take.

Kruse CA, Lillehei KO, Mitchell DH, Kleinschmidt-DeMasters B, Bellgrau D.

Proc Natl Acad Sci U S A. 1990 Dec;87(24):9577-81.

17.

Honokiol crosses BBB and BCSFB, and inhibits brain tumor growth in rat 9L intracerebral gliosarcoma model and human U251 xenograft glioma model.

Wang X, Duan X, Yang G, Zhang X, Deng L, Zheng H, Deng C, Wen J, Wang N, Peng C, Zhao X, Wei Y, Chen L.

PLoS One. 2011 Apr 29;6(4):e18490. doi: 10.1371/journal.pone.0018490.

18.

Therapeutic efficacy of antitumor dendritic cell vaccinations correlates with persistent Th1 responses, high intratumor CD8+ T cell recruitment and low relative regulatory T cell infiltration.

Driessens G, Gordower L, Nuttin L, Stordeur P, Blocklet D, Egrise D, Velu T, Bruyns C.

Cancer Immunol Immunother. 2008 Dec;57(12):1745-56. doi: 10.1007/s00262-008-0500-y. Epub 2008 Mar 28.

PMID:
18369621
19.

The combination of X-ray-mediated radiosurgery and gene-mediated immunoprophylaxis for advanced intracerebral gliosarcomas in rats.

Smilowitz HM, Coderre JA, Nawrocky MM, Tu W, Pinkerton A, Jahng GH, Gebbers N, Slatkin DN.

J Neurooncol. 2002 Mar;57(1):9-18.

PMID:
12125969
20.

Supplemental Content

Support Center